Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children

Temesgen E Andargie1,2, Katerina Roznik3, Neelam Redekar4

  • 1Genomic Research Alliance for Transplantation (GRAfT) and Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, Maryland, USA. GFAfT is detailed in Supplemental Acknowledgments.

Insights

Multisystem inflammatory syndrome in children (MIS-C) involves significant tissue injury, primarily driven by innate immune responses. Cell-free DNA (cfDNA) analysis reveals damage in various tissues, offering insights into MIS-C pathogenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pediatrics

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a severe hyperinflammatory condition linked to SARS-CoV-2 infection.
  • The precise mechanisms of systemic tissue injury in MIS-C remain poorly understood.
  • Understanding MIS-C pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the spectrum of tissue injury in MIS-C using epigenomics and cytokine profiling.
  • To elucidate the role of innate immunity in MIS-C pathogenesis.
  • To evaluate cell-free DNA (cfDNA) as a biomarker for tissue damage in MIS-C.

Main Methods:

  • Analysis of plasma cell-free DNA (cfDNA) epigenomics in MIS-C patients, pediatric COVID-19 (pCOVID-19) patients, and pediatric healthy controls (pHCs).
  • Measurement of plasma cytokine levels.
  • Correlation analysis between cfDNA origins, cytokine levels, and clinical presentation.

Main Results:

  • MIS-C patients exhibited elevated cfDNA levels originating from innate immune cells, megakaryocyte-erythroid precursors, and non-hematopoietic tissues (liver, heart, kidney).
  • cfDNA profiles in MIS-C showed significant interindividual variability, reflecting heterogeneous clinical symptoms.
  • Innate immune cell cfDNA levels correlated with inflammatory cytokines and non-hematopoietic tissue cfDNA, suggesting innate immunity drives multisystem pathology.

Conclusions:

  • MIS-C pathogenesis is predominantly mediated by innate immunity, leading to widespread tissue injury.
  • cfDNA analysis is a sensitive tool for mapping tissue damage in MIS-C.
  • cfDNA holds potential as a biomarker for various multiorgan inflammatory conditions.